Cardiologist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Chiropractor providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Dentist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Dermatologist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Family Physician providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
OB-GYN providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Ophthalmologist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Orthopedic Surgeon providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Pediatrician providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Physical Therapist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Podiatrist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Psychiatrist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Gregory A. Maggass, MD is board certified in radiation oncology, with a focus on the treatment of prostate cancer with both brachytherapy and IMRT/IGRT radiation therapy. Dr. Maggass has extensive experience with brachytherapy treatment using radioactive seeds, otherwise known as Internal Radiation Therapy. He is a pioneer in bringing Brachytherapy to patients in Arizona treating prostate, skin, eye and breast cancers. Dr. Maggass also specializes in PLUVICTO for prostate cancer treatment and LUTATHERA for neuroendocrine cancer treatment.
Passionate about advancing treatments in cancer care, Dr. Maggass played an instrumental role in developing improved treatments for delivering radiation, as well as combining radiation with surgical techniques and chemotherapy.
For nearly two decades, Dr. Maggass served as the Medical Director for Arizona Oncology Services in the East Valley. In this role, he started and lead the prostate brachytherapy program at Banner Desert Medical Center and Banner Baywood. In 2012, Dr. Maggass partnered with Arizona Center for Cancer Care to expand the groups footprint into the East Valley.
Dr. Maggass received his Medical Degree from the Medical College of Wisconsin. He completed his residency at the University of Southern California Medical Center, where he received specialized training in Brachytherapy.
Dr. Maggass is a multi-year “Top Doc” honoree by Phoenix Magazine, and “Best Doctors in America” honoree by Best Doctors, Inc.
"I needed a calm, straight forward explanation of my situation to make a choice in treatment. Dr. Maggass took his time and was genuinely engaged when he talked to my wife and I and he even let me talk once more on the phone when I had more questions. I would recommend him." -Wade
"Dr Maggass has been fantastic! Excellent bedside manner, and has always been forthright me. We are early on in this journey, but feel I am in good hands with both doctor, and his wonderful staff." -Jeff
Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.
PHILOSOPHY
I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.
RESEARCH PUBLICATIONS
Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358. 2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282. 3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228 4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240. 5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053
Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.
PHILOSOPHY
I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.
RESEARCH PUBLICATIONS
Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358. 2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282. 3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228 4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240. 5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053
Dr. DiPasquale is a specialized breast surgeon with expertise in treating both malignant and benign breast diseases. Her passion lies in advanced oncoplastic reconstructive surgery, where she combines oncological principles with plastic surgery techniques. She strives to ensure excellent oncological outcomes while also prioritizing cosmetic results and patient satisfaction.
Originally from the east coast of Canada, Dr. DiPasquale completed her medical training at Dalhousie University. Following this, she pursued her General Surgery Residency at the University of Alberta. During her residency, she also earned a Master of Science degree at the prestigious Harvard T.H. Chan School of Public Health, where her research was recognized with an award from the Canadian Federation of University Women.
To further refine her skills and broaden her expertise, Dr. DiPasquale completed a breast oncoplastic and reconstruction surgery fellowship at the renowned Paris Breast Center. She is proud to hold board certifications from both the Royal College of Physicians and Surgeons of Canada and the American Board of Surgery.
Dr. DiPasquale's contributions extend beyond her clinical practice. She has co-authored numerous research papers and actively presents her work at international conferences. Additionally, she serves as a peer reviewer for international journals.
Outside of her professional endeavors, Dr. DiPasquale cherishes quality time spent with her loved ones, including her family, friends, and her beloved Yorkie. After escaping the cold Canadian winters, she also enjoys spending time outdoors in the warm Arizona sun.
Dr. Parmjeet Kumar Banghar specializes in hematology, medical oncology, and internal medicine. He joined Arizona Center for Cancer Care in 2008 when his team at Arizona Center for Hematology and Oncology partnered with the practice.
Currently, Dr. Banghar is a member of the American Society of Clinical Oncology and American Society of Hematology. He has participated in a research study involving cerebrovascular diseases and been published in several journals, including Leukemia Research and the Indian Journal of Medical Sciences. He has also presented on a number of topics, including sonographic evaluation of the spleen in sickle cell syndromes, lennox gastaut syndrome and sweet syndrome in a patient with acute myeloid leukemia.
"This doctor is smart and knows cancer. The staff is the best. My nurses who give me shots are the best! Highly reccomend this office." -Lina
"I have been Dr. Banghar's patient since 2019 and just found out I could give him a review. Wish I had been told this before. He is an excellent provider. He has made me feel confident about my treatment which I think has/had a tremendous amount of impact on my care and the outcome. I would recommend him and the facility in a heart beat." -Felicia
Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.
PHILOSOPHY
I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.
RESEARCH PUBLICATIONS
Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358. 2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282. 3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228 4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240. 5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053
Dr. Scott P. Tannehill is Board Certified in Radiation Oncology with over two decades of clinical experience. He has been in practice in Arizona since 2008 and was a co-founder of Arizona Breast Cancer Specialists and Arizona Radiation Oncology Specialists, both of which joined Arizona Center for Cancer Care in 2012.
Dr. Tannehill earned his medical degree and specialty training at the University of Wisconsin. He has held faculty positions at several top-tier universities, including the University of Wisconsin, the University of Florida, and the University of Arizona. He was Chair of the Oncology Curriculum for the University of Wisconsin for several years. He worked a sabbatical year at the Peter MacCallum Cancer Centre in Melbourne, Australia before moving to Arizona and joining the faculty at the University of Arizona - Tucson, where he served as the Program Director for the Radiation Oncology Residency. Dr. Tannehill continues to hold the academic title of Clinical Associate Professor of Radiation Oncology with the University of Arizona and continues to educate medical trainees.
Dr. Tannehill has extensive clinical expertise in brachytherapy, Intensity-Modulated Radiation Therapy (IMRT), and LUTATHERA. He has been invited to present on his techniques and experience both nationally and internationally. His research interests include treatment techniques for breast cancer, brachytherapy for breast and other cancers, and participation in cooperative group clinical research.
Dr. Tannehill is a member of the European Society for Therapeutic Radiology and Oncology, American Society of Hematology, American Society of Clinical Oncology and American Society for Therapeutic Radiology and Oncology. He is board certified in Radiation Oncology by the American Board of Radiology.
Dr. Tannehill is a multi-year “Top Doc” honoree by Phoenix Magazine and has been named among the “Best Doctors in America” by Best Doctors, Inc since 2003.
"Dr. Scott Tannehill, MD was not only professional, he was kind, caring and made the process that much easier. His staff was kind and caring and they are all very efficient and helpful. I would recommend Dr. Tannehill to anyone!" -Nancy
"Dr. Tannehill is the best doctor I have ever meet. He’s very professional and informative he makes me feel very comfortable to express my problems." -Khlem
Dr. Sara Zakem is a board-certified radiation oncologist with expertise in the management of all cancer types using advanced techniques including brachytherapy, Stereotactic Body Radiotherapy (SBRT), Stereotactic Radiosurgery (SRS),Intensity Modulated Radiation Therapy (IMRT), Volumetric Modulated Arc Therapy (VMAT) and Image Guided Radiotherapy (IGRT). Originally from Grand Rapids, MI, Dr. Zakem served as chief resident of radiation oncology at the University of Colorado before beginning her career as a radiation oncologist at the University of Washington. She joined Arizona Center for Cancer Care after moving to Phoenix with her husband, a head and neck cancer surgeon, in 2023.
Dr. Zakem is an active member of the radiation oncology community, serving on the American Society for Radiation Oncology (ASTRO) Early Career Committee and the American College of Radiation Oncology (ACRO) New Practitioner and Communications Committees. As a resident, she additionally served as the Communications Chair for the Society for Women in Radiation Oncology (SWRO) and was elected to the Gold Humanism Honor Society by her colleagues for her commitment to providing compassionate, patient-centered care. She has authored numerous peer-reviewed publications on esophageal, pancreatic, gynecologic, and head and neck cancers.
Having been personally touched by cancer, Dr. Zakem recognizes that receiving a cancer diagnosis is often one of the most frightening and confusing times for a patient and their loved ones. She is dedicated to taking the time needed to help patients understand and navigate their cancer diagnoses, clearly communicating the role of radiation therapy and how it can best be used to help patients achieve their goals of care.
In her free time, Dr. Zakem enjoys spending time with her husband and two cats, live music, yoga, skiing, spending time outdoors, and rooting for her Michigan Wolverines - Go Blue!
Dr. Sara Zakem is a board-certified radiation oncologist with expertise in the management of all cancer types using advanced techniques including brachytherapy, Stereotactic Body Radiotherapy (SBRT), Stereotactic Radiosurgery (SRS),Intensity Modulated Radiation Therapy (IMRT), Volumetric Modulated Arc Therapy (VMAT) and Image Guided Radiotherapy (IGRT). Originally from Grand Rapids, MI, Dr. Zakem served as chief resident of radiation oncology at the University of Colorado before beginning her career as a radiation oncologist at the University of Washington. She joined Arizona Center for Cancer Care after moving to Phoenix with her husband, a head and neck cancer surgeon, in 2023.
Dr. Zakem is an active member of the radiation oncology community, serving on the American Society for Radiation Oncology (ASTRO) Early Career Committee and the American College of Radiation Oncology (ACRO) New Practitioner and Communications Committees. As a resident, she additionally served as the Communications Chair for the Society for Women in Radiation Oncology (SWRO) and was elected to the Gold Humanism Honor Society by her colleagues for her commitment to providing compassionate, patient-centered care. She has authored numerous peer-reviewed publications on esophageal, pancreatic, gynecologic, and head and neck cancers.
Having been personally touched by cancer, Dr. Zakem recognizes that receiving a cancer diagnosis is often one of the most frightening and confusing times for a patient and their loved ones. She is dedicated to taking the time needed to help patients understand and navigate their cancer diagnoses, clearly communicating the role of radiation therapy and how it can best be used to help patients achieve their goals of care.
In her free time, Dr. Zakem enjoys spending time with her husband and two cats, live music, yoga, skiing, spending time outdoors, and rooting for her Michigan Wolverines - Go Blue!
Dr. Scott P. Tannehill is Board Certified in Radiation Oncology with over two decades of clinical experience. He has been in practice in Arizona since 2008 and was a co-founder of Arizona Breast Cancer Specialists and Arizona Radiation Oncology Specialists, both of which joined Arizona Center for Cancer Care in 2012.
Dr. Tannehill earned his medical degree and specialty training at the University of Wisconsin. He has held faculty positions at several top-tier universities, including the University of Wisconsin, the University of Florida, and the University of Arizona. He was Chair of the Oncology Curriculum for the University of Wisconsin for several years. He worked a sabbatical year at the Peter MacCallum Cancer Centre in Melbourne, Australia before moving to Arizona and joining the faculty at the University of Arizona - Tucson, where he served as the Program Director for the Radiation Oncology Residency. Dr. Tannehill continues to hold the academic title of Clinical Associate Professor of Radiation Oncology with the University of Arizona and continues to educate medical trainees.
Dr. Tannehill has extensive clinical expertise in brachytherapy, Intensity-Modulated Radiation Therapy (IMRT), and LUTATHERA. He has been invited to present on his techniques and experience both nationally and internationally. His research interests include treatment techniques for breast cancer, brachytherapy for breast and other cancers, and participation in cooperative group clinical research.
Dr. Tannehill is a member of the European Society for Therapeutic Radiology and Oncology, American Society of Hematology, American Society of Clinical Oncology and American Society for Therapeutic Radiology and Oncology. He is board certified in Radiation Oncology by the American Board of Radiology.
Dr. Tannehill is a multi-year “Top Doc” honoree by Phoenix Magazine and has been named among the “Best Doctors in America” by Best Doctors, Inc since 2003.
"Dr. Scott Tannehill, MD was not only professional, he was kind, caring and made the process that much easier. His staff was kind and caring and they are all very efficient and helpful. I would recommend Dr. Tannehill to anyone!" -Nancy
"Dr. Tannehill is the best doctor I have ever meet. He’s very professional and informative he makes me feel very comfortable to express my problems." -Khlem
Dr. Dhillon is fellowship trained in Hematology and Medical Oncology. His clinical interests include a broad spectrum of disorders including solid tumors, hematologic malignancies, and benign hematologic disorders. His special interests include pancreatic cancer, breast cancer, myeloma, lymphoma, gastrointestinal malignancies, prostate cancer, and lung cancer. Dr. Dhillon also specializes in treatment of blood disorders.
Dr. Dhillon has participated in a number of research projects. He has presented his work at national meetings, and published in journals, including the New England Journal of Medicine.
He is an advocate of collaborative and patient-centered cancer care that delivers effective treatment while maintaining quality of life.
Dr. Dhillon enjoys golf, writing, activities related to personal fitness, hiking, traveling, and spending time with friends and family.
"I am a snowbird and had no idea who would be a good oncologist during the winter to treat me. When I read about him online, he was one of my top choices and I’m glad I picked him. He has been the perfect fit for me. Not only does he have a friendly personality, but he is very thorough and caring. He is also very efficient as well. If he says he will do something, you can depend on him to do it. I feel that I am in very good hands here. Thank you Dr. Dhillon! I will tell my Idaho friends about you." -Marilyn
"When I come to Dr Dhillon’s office I can honestly say that I have never felt so loved and cared for in any physician’s office. The staff there is excellent beginning with checking in. They are so polite and helpful. All of the nurses take a personal interest to aid me to get my most outstanding care. The encouragement I get from all of them is phenomenal! I may come in down and dejected but by the time I leave I feel like there is a bright light at the end of the tunnel!!" [click the link below to read the rest] -Linda
Dr. Sara Zakem is a board-certified radiation oncologist with expertise in the management of all cancer types using advanced techniques including brachytherapy, Stereotactic Body Radiotherapy (SBRT), Stereotactic Radiosurgery (SRS),Intensity Modulated Radiation Therapy (IMRT), Volumetric Modulated Arc Therapy (VMAT) and Image Guided Radiotherapy (IGRT). Originally from Grand Rapids, MI, Dr. Zakem served as chief resident of radiation oncology at the University of Colorado before beginning her career as a radiation oncologist at the University of Washington. She joined Arizona Center for Cancer Care after moving to Phoenix with her husband, a head and neck cancer surgeon, in 2023.
Dr. Zakem is an active member of the radiation oncology community, serving on the American Society for Radiation Oncology (ASTRO) Early Career Committee and the American College of Radiation Oncology (ACRO) New Practitioner and Communications Committees. As a resident, she additionally served as the Communications Chair for the Society for Women in Radiation Oncology (SWRO) and was elected to the Gold Humanism Honor Society by her colleagues for her commitment to providing compassionate, patient-centered care. She has authored numerous peer-reviewed publications on esophageal, pancreatic, gynecologic, and head and neck cancers.
Having been personally touched by cancer, Dr. Zakem recognizes that receiving a cancer diagnosis is often one of the most frightening and confusing times for a patient and their loved ones. She is dedicated to taking the time needed to help patients understand and navigate their cancer diagnoses, clearly communicating the role of radiation therapy and how it can best be used to help patients achieve their goals of care.
In her free time, Dr. Zakem enjoys spending time with her husband and two cats, live music, yoga, skiing, spending time outdoors, and rooting for her Michigan Wolverines - Go Blue!
Dr. Scott P. Tannehill is Board Certified in Radiation Oncology with over two decades of clinical experience. He has been in practice in Arizona since 2008 and was a co-founder of Arizona Breast Cancer Specialists and Arizona Radiation Oncology Specialists, both of which joined Arizona Center for Cancer Care in 2012.
Dr. Tannehill earned his medical degree and specialty training at the University of Wisconsin. He has held faculty positions at several top-tier universities, including the University of Wisconsin, the University of Florida, and the University of Arizona. He was Chair of the Oncology Curriculum for the University of Wisconsin for several years. He worked a sabbatical year at the Peter MacCallum Cancer Centre in Melbourne, Australia before moving to Arizona and joining the faculty at the University of Arizona - Tucson, where he served as the Program Director for the Radiation Oncology Residency. Dr. Tannehill continues to hold the academic title of Clinical Associate Professor of Radiation Oncology with the University of Arizona and continues to educate medical trainees.
Dr. Tannehill has extensive clinical expertise in brachytherapy, Intensity-Modulated Radiation Therapy (IMRT), and LUTATHERA. He has been invited to present on his techniques and experience both nationally and internationally. His research interests include treatment techniques for breast cancer, brachytherapy for breast and other cancers, and participation in cooperative group clinical research.
Dr. Tannehill is a member of the European Society for Therapeutic Radiology and Oncology, American Society of Hematology, American Society of Clinical Oncology and American Society for Therapeutic Radiology and Oncology. He is board certified in Radiation Oncology by the American Board of Radiology.
Dr. Tannehill is a multi-year “Top Doc” honoree by Phoenix Magazine and has been named among the “Best Doctors in America” by Best Doctors, Inc since 2003.
"Dr. Scott Tannehill, MD was not only professional, he was kind, caring and made the process that much easier. His staff was kind and caring and they are all very efficient and helpful. I would recommend Dr. Tannehill to anyone!" -Nancy
"Dr. Tannehill is the best doctor I have ever meet. He’s very professional and informative he makes me feel very comfortable to express my problems." -Khlem
Getting diagnosed with cancer is very difficult for patients and their families but getting treatment for cancer should not be. Dr. Agarwal approaches all cancer patients with the goal of giving them the most up-to-date and individualized cancer treatment in an efficient way so they can continue to live their lives as close to normal as possible
Dr. Agarwal specializes in all different types of cancer and blood related problems such as lung, gastrointestinal, prostate, genitourinary, gynecologic, neurologic, lymphomas, leukemia, anemia, platelets clotting disorders, etc. He is also interested in clinical trials and has completed advanced training in clinical trials and research. In addition, he has published several papers and has presented at national and international cancer meetings.
In his free time, Dr. Agarwal enjoys traveling, watching movies, playing tennis and golf.
Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.
PHILOSOPHY
I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.
RESEARCH PUBLICATIONS
Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358. 2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282. 3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228 4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240. 5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053
Dr. Angeles is a board-certified general surgeon with advanced training in benign and malignant breast diseases. She is committed to a multidisciplinary approach to treating breast cancer, working closely with the other sub-specialists in oncology to provide the best treatment plan for each patient. She also incorporates oncoplastic techniques to provide optimal cosmetic outcomes after breast conservation surgery.
Dr. Angeles received her medical degree from Western University of Health Sciences, College of Osteopathic Medicine of the Pacific. She completed her general surgery residency at Philadelphia College of Osteopathic Medicine in Pennsylvania. Having a special interest in breast cancer, she went on to complete a breast surgical oncology fellowship at Medstar Washington Hospital Center in Washington, D.C
In her spare time, she loves to travel, support her sons at their basketball games, and hike during the cooler months in and around Arizona.
"I was referred to Dr. Angeles for a breast consult. I had been diagnosed with LCIS and she was very informative and thorough. She ended up doing another biopsy/lumpectomy and found a 2.5mm cancerous tumor. After another surgery to check my lymph nodes I was referred for radiation therapy. Dr. Angeles was so wonderful during this whole process. Her bedside manner is top notch. All her staff and nurses were amazing as well. I have had very little down time considering everything that has happened. She got the ball rolling quickly with all of my care and I am so grateful." -Cathie
"She is probably the most empathetic doctor I have ever met. She truly cares about her patients, not just the cancer, but your whole being. She reassuring and comforting when patients like me are at their worst. Highly recommend." -Ginny
Getting diagnosed with cancer is very difficult for patients and their families but getting treatment for cancer should not be. Dr. Agarwal approaches all cancer patients with the goal of giving them the most up-to-date and individualized cancer treatment in an efficient way so they can continue to live their lives as close to normal as possible
Dr. Agarwal specializes in all different types of cancer and blood related problems such as lung, gastrointestinal, prostate, genitourinary, gynecologic, neurologic, lymphomas, leukemia, anemia, platelets clotting disorders, etc. He is also interested in clinical trials and has completed advanced training in clinical trials and research. In addition, he has published several papers and has presented at national and international cancer meetings.
In his free time, Dr. Agarwal enjoys traveling, watching movies, playing tennis and golf.
Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.
PHILOSOPHY
I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.
RESEARCH PUBLICATIONS
Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358. 2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282. 3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228 4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240. 5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053
